Progenics reports lower losses
-
- March
- 15
Progenics Pharmaceuticals Inc., an Eastview-based biotech research firm, reported lower losses for the fourth quarter and the year as it collected reimbursements from its research partner Wyeth.
For the fourth quarter, Progenics has a net loss of $1.71 million, or 7 cents a share, on revenue of $21.9 million. For the fourth quarter of 2005, it had a net loss of $32.7 million, or $1.34, on revenue of $2.05 million.
For fiscal 2006, Progenics had a net loss of $21.6 million, or 84 cents a share, on revenue of $69.9 million. For fiscal 2005, it had a net loss of $69.4 million, or $3.33 a share, on revenue of $9.49 million.
This entry was posted
on Thursday, March 15th, 2007 at 5:30 pm by Mike Bieger.
You can follow any responses to this entry through the RSS 2.0 feed.
Category: Uncategorized
Print
| 
Email
